Rhythm Pharmaceuticals buy Bank of America Co.
Start price
07.04.25
/
50%
€50.50
Target price
07.04.26
€57.38
Performance (%)
30.69%
Price
31.03.26
€69.50
This prediction will end soon
Summary
This prediction is currently active. With a performance of 30.69% the BUY prediction by Bank_of_America_Co_ is a big success. This prediction currently runs until 07.04.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 0.000% | 0.000% |
| iShares Core DAX® | 0,75 % | -8,50 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % |
| iShares S&P 500 | -0,59 % | -2,87 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $63.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€120.90
17.03.27
17.03.27
-14.84%
31.03.26
31.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€76.50
10.07.25
10.07.25
€80.90
10.07.26
10.07.26
-13.73%
31.03.26
31.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€20.80
01.08.23
01.08.23
-
01.08.24
01.08.24
97.12%
02.08.24
02.08.24